search
Back to results

Strength Training for Skeletal Muscle Adaptation After Stroke

Primary Purpose

Stroke

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Exercise- Strength Training
Exercise- Stretching Control
Sponsored by
VA Office of Research and Development
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke focused on measuring Stroke, Exercise, Strength Training, Skeletal Muscle, Insulin Sensitivity

Eligibility Criteria

40 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Stroke greater than 6 months prior with residual hemiparetic gait in women or men aged 40-85 years
  • Completion of all regular post-stroke physical therapy
  • Adequate language and neurocognitive function to participate in testing and training and to give adequate informed consent

Exclusion Criteria:

  • Alcohol consumption greater than 3 oz. liquor, or 3 x 4 oz glasses of wine, or 3 x 12 oz. beers per day, by self-report
  • clinical history of:

    • unstable angina
    • recent (less than 3 months) myocardial infarction or congestive heart failure (NYHA category II)
    • hemodynamically significant valvular dysfunction
    • peripheral arterial occlusive disease (PAOD) with claudication
    • major orthopedic, chronic pain, or non-stroke neuromuscular disorders restricting exercise
    • pulmonary or renal failure
    • poorly controlled hypertension (greater than 190/110)
    • recent hospitalization for severe disease or surgery
    • severe or global receptive aphasia which confounds reliable testing and training
  • Allergy to lidocaine
  • Known muscle disorder
  • Taking Coumadin or Lovenox (contraindication for muscle biopsies)
  • Dementia
  • Untreated major depression

Sites / Locations

  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Arm 1

Arm 2

Arm Description

Participants in this group undergo lower-extremity strength training on three pneumatic resistance machines (Keiser Leg Press, Keiser Leg Extension, and Keiser Leg Curl). Training sessions happen 3 times per week (M,W,F) and last approximately 45 minutes to 1 hour. Participants in this group exercise each limb individually to account for the large discrepancies in strength between legs in stroke survivors.

Participants in this group receive equal exposure to study staff compared with the experimental ST group (approximately 45 minutes to 1 hour 3 times per week). Exercise sessions for this group involve a full battery of active and passive...upper and lower body...stretching and range of motion exercises performed on raised padded tables.

Outcomes

Primary Outcome Measures

Change in 1-repetition Maximum (RM) Muscle Strength (Leg Press, Paretic Side)
Change in 1-RM Muscle Strength (Leg Press, Non-Paretic Side)
Change in 1-RM Muscle Strength (Leg Extension, Paretic Side)
Change in 1-RM Muscle Strength (Leg Extension, Non-Paretic Side)
Change in Leg Muscle Endurance (Paretic Side)
Tests how training impacts the total number of submaximal repetitions a participant can perform according to standardized cadence (at the same absolute level of resistance, pre and post).
Change in Leg Muscle Endurance (Non-Paretic Side)
Tests how training impacts the total number of submaximal repetitions a participant can perform according to standardized cadence (at the same absolute level of resistance, pre and post).
Change in 6-minute Walk Distance
Change in 10 Meter Walking Speed (Self-Selected)
Change in 10 Meter Walking Speed (Fastest)
Change in Peak Aerobic Capacity (VO2 Peak)
Change in Berg Balance Scale
This measure is a 14 item scale, with each item scored (0-4) and summed for a maximum score of 56 points. Range is 0-56 and higher values represent a better outcome.
Change in Paretic Limb Step Time (Self-Selected)
This and other measures come from Instrumented Walkway (Gait Rite)
Change in Paretic Limb Step Time (Fastest)
This and other measures come from Instrumented Walkway (Gait Rite)
Change in Non-Paretic Limb Step Time (Self-Selected)
This and other measures come from Instrumented Walkway (Gait Rite)
Change in Non-Paretic Limb Step Time (Fastest)
This and other measures come from Instrumented Walkway (Gait Rite)
Change in Paretic Limb Step Length (Self-Selected)
This and other measures come from Instrumented Walkway (Gait Rite)
Change in Paretic Limb Step Length (Fastest)
This and other measures come from Instrumented Walkway (Gait Rite)
Change in Non-Paretic Limb Step Length (Self-Selected)
This and other measures come from Instrumented Walkway (Gait Rite)
Change in Non-Paretic Limb Step Length (Fastest)
This and other measures come from Instrumented Walkway (Gait Rite)

Secondary Outcome Measures

Full Information

First Posted
January 22, 2009
Last Updated
June 7, 2018
Sponsor
VA Office of Research and Development
search

1. Study Identification

Unique Protocol Identification Number
NCT00827827
Brief Title
Strength Training for Skeletal Muscle Adaptation After Stroke
Official Title
Strength Training for Skeletal Muscle Adaptation After Stroke
Study Type
Interventional

2. Study Status

Record Verification Date
June 2018
Overall Recruitment Status
Completed
Study Start Date
April 1, 2009 (Actual)
Primary Completion Date
August 31, 2013 (Actual)
Study Completion Date
June 6, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
VA Office of Research and Development

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Chronically disabled stroke survivors experience accelerated skeletal muscle atrophy and other detrimental changes to muscle and surrounding tissues on the paretic side. This unilateral tissue-level damage contributes to worsening disability and insulin resistance. This VA Merit Award will advance the investigators' understanding of the potential for strength training (ST) to reverse stroke-related muscle abnormalities to improve metabolic health, strength, and function. It will be the first study to thoroughly investigate the effects of ST on muscle atrophy, intramuscular fat, muscle fiber characteristics, capillary density and insulin sensitivity after stroke.
Detailed Description
This study investigates the hypothesis that a novel, high intensity, high repetition ST program will improve abnormalities in paretic and non-paretic leg muscle volume and composition compared to an attention-matched control regimen of supervised stretching over a 3-month intervention period in those disabled by stroke. The investigators further hypothesize that ST-induced skeletal muscle adaptation will translate into improved insulin sensitivity, strength, and function in this population. The specific objectives are to: 1) Determine the effects ST compared to a control intervention on paretic and non-paretic abnormalities in skeletal muscle volume, intramuscular fat, muscle fiber distribution, muscle capillary density, and muscle inflammation in chronically disabled stroke survivors. 2) Determine the effects ST compared to a control intervention on insulin sensitivity in stroke survivors, and whether structural and cellular skeletal muscle mechanisms contribute to improvements in insulin sensitivity after ST. 3) Determine the effects ST compared to a control intervention on physical function (strength, walking speed and balance) in stroke survivors, and whether structural skeletal muscle mechanisms predict ST-induced functional improvement. The project design consists of 4 phases over 5 months for stroke participants enrolled in either of the two intervention arms (ST vs. CONTROL). During phase 1 the investigators will screen and consent chronic stroke patients with residual gait deficits. Phase 2 (3 weeks) will consist of baseline testing that includes dual energy X-ray absorptiometry (DEXA) scanning, bilateral CT scanning of the legs, bilateral vastus lateralis muscle biopsies, strength testing, timed walks, balance measurements, oral glucose tolerance testing, and hyperglycemic clamp testing. Following completion of baseline testing, volunteers are to be randomized to ST or the CONTROL group. Phase 3 (Intervention Phase, 3 months) will begin with 2 sessions of acclimatization for those assigned to the ST group. ST will then be progressed to 2 sets of 20 repetitions on each leg on each machine (Keiser Leg Press, Leg Extension, Leg Curl) with gradual increases in resistance over 3 months. Those in the CONTROL group will receive equal exposure to health care personnel in the Baltimore VA Exercise facility, performing a full battery of upper and lower body passive and active stretching exercises at each intervention session. In Phase 4 all baseline testing and laboratory analyses will be repeated. Developing evidence-based therapies to combat skeletal muscle deterioration is highly relevant for chronically disabled stoke survivors. There is mounting evidence that current models of post-stroke rehabilitation are not optimal for maximizing recovery of muscle mass, strength, and metabolic health. The proposed research will develop new insight into the utility of progressive ST for reversing detrimental changes to gross muscle composition, muscle molecular phenotype, muscle inflammation, and muscle capillarization. Changes to any or all of these muscle parameters should have measurable impact on both whole body insulin sensitivity and function. Collectively, the results from this trial may change the current standard of care for stroke survivors by providing evidenced reasons for augmenting physical therapists' treatments, allowing more intense and diverse therapy sessions for maintenance of skeletal muscle.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
Stroke, Exercise, Strength Training, Skeletal Muscle, Insulin Sensitivity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
38 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Arm 1
Arm Type
Experimental
Arm Description
Participants in this group undergo lower-extremity strength training on three pneumatic resistance machines (Keiser Leg Press, Keiser Leg Extension, and Keiser Leg Curl). Training sessions happen 3 times per week (M,W,F) and last approximately 45 minutes to 1 hour. Participants in this group exercise each limb individually to account for the large discrepancies in strength between legs in stroke survivors.
Arm Title
Arm 2
Arm Type
Active Comparator
Arm Description
Participants in this group receive equal exposure to study staff compared with the experimental ST group (approximately 45 minutes to 1 hour 3 times per week). Exercise sessions for this group involve a full battery of active and passive...upper and lower body...stretching and range of motion exercises performed on raised padded tables.
Intervention Type
Other
Intervention Name(s)
Exercise- Strength Training
Intervention Description
3x per week lower-extremity ST lasting approximately 45 minutes to 1 hour.
Intervention Type
Other
Intervention Name(s)
Exercise- Stretching Control
Intervention Description
3x per week upper and lower body stretching mixed with active and passive range of motion exercises
Primary Outcome Measure Information:
Title
Change in 1-repetition Maximum (RM) Muscle Strength (Leg Press, Paretic Side)
Time Frame
Baseline, 3 months
Title
Change in 1-RM Muscle Strength (Leg Press, Non-Paretic Side)
Time Frame
Baseline, 3 months
Title
Change in 1-RM Muscle Strength (Leg Extension, Paretic Side)
Time Frame
Baseline, 3 Months
Title
Change in 1-RM Muscle Strength (Leg Extension, Non-Paretic Side)
Time Frame
Baseline, 3 Months
Title
Change in Leg Muscle Endurance (Paretic Side)
Description
Tests how training impacts the total number of submaximal repetitions a participant can perform according to standardized cadence (at the same absolute level of resistance, pre and post).
Time Frame
Baseline, 3 Months
Title
Change in Leg Muscle Endurance (Non-Paretic Side)
Description
Tests how training impacts the total number of submaximal repetitions a participant can perform according to standardized cadence (at the same absolute level of resistance, pre and post).
Time Frame
Baseline, 3 months
Title
Change in 6-minute Walk Distance
Time Frame
Baseline, 3 Months
Title
Change in 10 Meter Walking Speed (Self-Selected)
Time Frame
Baseline, 3 months
Title
Change in 10 Meter Walking Speed (Fastest)
Time Frame
Baseline, 3 Months
Title
Change in Peak Aerobic Capacity (VO2 Peak)
Time Frame
Baseline, 3 Months
Title
Change in Berg Balance Scale
Description
This measure is a 14 item scale, with each item scored (0-4) and summed for a maximum score of 56 points. Range is 0-56 and higher values represent a better outcome.
Time Frame
Baseline, 3 months
Title
Change in Paretic Limb Step Time (Self-Selected)
Description
This and other measures come from Instrumented Walkway (Gait Rite)
Time Frame
Baseline, 3 months
Title
Change in Paretic Limb Step Time (Fastest)
Description
This and other measures come from Instrumented Walkway (Gait Rite)
Time Frame
Baseline, 3 Months
Title
Change in Non-Paretic Limb Step Time (Self-Selected)
Description
This and other measures come from Instrumented Walkway (Gait Rite)
Time Frame
Baseline, 3 months
Title
Change in Non-Paretic Limb Step Time (Fastest)
Description
This and other measures come from Instrumented Walkway (Gait Rite)
Time Frame
Baseline, 3 Months
Title
Change in Paretic Limb Step Length (Self-Selected)
Description
This and other measures come from Instrumented Walkway (Gait Rite)
Time Frame
Baseline, 3 Months
Title
Change in Paretic Limb Step Length (Fastest)
Description
This and other measures come from Instrumented Walkway (Gait Rite)
Time Frame
Baseline, 3 months
Title
Change in Non-Paretic Limb Step Length (Self-Selected)
Description
This and other measures come from Instrumented Walkway (Gait Rite)
Time Frame
Baseline, 3 Months
Title
Change in Non-Paretic Limb Step Length (Fastest)
Description
This and other measures come from Instrumented Walkway (Gait Rite)
Time Frame
Baseline, 3 Months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Stroke greater than 6 months prior with residual hemiparetic gait in women or men aged 40-85 years Completion of all regular post-stroke physical therapy Adequate language and neurocognitive function to participate in testing and training and to give adequate informed consent Exclusion Criteria: Alcohol consumption greater than 3 oz. liquor, or 3 x 4 oz glasses of wine, or 3 x 12 oz. beers per day, by self-report clinical history of: unstable angina recent (less than 3 months) myocardial infarction or congestive heart failure (NYHA category II) hemodynamically significant valvular dysfunction peripheral arterial occlusive disease (PAOD) with claudication major orthopedic, chronic pain, or non-stroke neuromuscular disorders restricting exercise pulmonary or renal failure poorly controlled hypertension (greater than 190/110) recent hospitalization for severe disease or surgery severe or global receptive aphasia which confounds reliable testing and training Allergy to lidocaine Known muscle disorder Taking Coumadin or Lovenox (contraindication for muscle biopsies) Dementia Untreated major depression
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Frederick M Ivey, PhD
Organizational Affiliation
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Official's Role
Principal Investigator
Facility Information:
Facility Name
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21201
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
27865696
Citation
Ivey FM, Prior SJ, Hafer-Macko CE, Katzel LI, Macko RF, Ryan AS. Strength Training for Skeletal Muscle Endurance after Stroke. J Stroke Cerebrovasc Dis. 2017 Apr;26(4):787-794. doi: 10.1016/j.jstrokecerebrovasdis.2016.10.018. Epub 2016 Nov 16.
Results Reference
result
PubMed Identifier
23352685
Citation
Ivey FM, Ryan AS. Resistive training improves insulin sensitivity after stroke. J Stroke Cerebrovasc Dis. 2014 Feb;23(2):225-9. doi: 10.1016/j.jstrokecerebrovasdis.2012.12.014. Epub 2013 Jan 22.
Results Reference
result

Learn more about this trial

Strength Training for Skeletal Muscle Adaptation After Stroke

We'll reach out to this number within 24 hrs